betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas...

9

Transcript of betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas...

Page 1: betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company. With $11.8 billion worth products going off
Page 2: betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company. With $11.8 billion worth products going off
Page 3: betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company. With $11.8 billion worth products going off
Page 4: betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company. With $11.8 billion worth products going off
Page 5: betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company. With $11.8 billion worth products going off
Page 6: betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company. With $11.8 billion worth products going off
Page 7: betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company. With $11.8 billion worth products going off
Page 8: betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company. With $11.8 billion worth products going off
Page 9: betapharm, Germanys fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company. With $11.8 billion worth products going off